Gene · 4921
NIH grants1,545
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,381 to 1,400 of 1,545
Download this page as JSON| Grant | Title | DDR2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA125550 | Role of Fibroblasts in Cancer | 1 | 2010 |
| R01DK037340 | The Role of KLF6 Tumor Suppressor in Hepatocellular Cancer | 1 | 2010 |
| R01DK078243 | Modeling androgen receptor in prostate cells | 1 | 2010 |
| R01DK082690 | A Metabolomic Approach to Discovering Biomarkers for ADPKD | 1 | 2010 |
| R01EB008281 | A Multidimensional Alzheimer's Disease Brain Atlas | 1 | 2010 |
| R01GM060000 | Folding and Design of Beta Sheets in Membranes | 1 | 2010 |
| R01HL059165 | Collagenase Inhibition in Heart Failure | 1 | 2010 |
| R01HL059246 | Cardiac metabolism and heart failure | 1 | 2010 |
| R01HL067970 | AMP-activated protein kinase in hypertrophied hearts | 1 | 2010 |
| R01HL092508 | Regulation of Periostin by TGFbeta and BMP in Heart Development | 1 | 2010 |
| R03DA027977 | Probing Opioid-Induced Glial Activation with Peptide Antagonists | 1 | 2010 |
| R03DE019451 | Genetic Characterization of a Novel Model of Cleft Palate | 1 | 2010 |
| R21CA129906 | Molecular Biomarkers as Classifiers to Individualize Therapy of Esophagus Cancer | 1 | 2010 |
| R21CA138373 | Probing EBV-LMP-1's Transmembrane Activation Domain with Synthetic Peptide Antago | 1 | 2010 |
| R21CA139278 | Incorporation of microRNA expression in pharmacogenetic prediction models | 1 | 2010 |
| R21ES017146 | Translational Machinery in Stress Signaling and Tumor Suppression | 1 | 2010 |
| R21HL089679 | Directed Cell Fusion for the Treatment of Myocardial Infarction | 1 | 2010 |
| R37DK039588 | MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS | 1 | 2010 |
| R37MH059490 | Quantitative Trait Locus Mapping in Human Pedigrees | 1 | 2010 |
| RC1CA146299 | Deep Sequencing of Small Regulatory RNAs in Diffuse Large B cell Lymphoma | 1 | 2010 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/grants?page=70